Molecular mechanisms underlying the activation of mammalian primordial follicles

Endocrine Reviews

Volumn 30, Issue 5, 2009, Pages 438-464

  Adhikari, Deepak ^a   Liu, Kui ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; BASIC FIBROBLAST GROWTH FACTOR; BONE MORPHOGENETIC PROTEIN 4; BRAIN DERIVED NEUROTROPHIC FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR RECEPTOR; CYCLIN DEPENDENT KINASE; GROWTH DIFFERENTIATION FACTOR 9; GROWTH HORMONE RECEPTOR; HUMAN GROWTH HORMONE; INSULIN; KERATINOCYTE GROWTH FACTOR; LEUKEMIA INHIBITORY FACTOR; MUELLERIAN INHIBITING FACTOR; NEUROTROPHIN 3 RECEPTOR; NEUROTROPHIN RECEPTOR P75; NEUROTROPIN; NEUROTROPIN 3; NEUROTROPIN 4; OSTEOGENIC PROTEIN 1; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PLATELET DERIVED GROWTH FACTOR; PROTEIN P27; PROTEIN TYROSINE KINASE A; SMAD PROTEIN; STROMAL CELL DERIVED FACTOR 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FKHRL1; TRANSCRIPTION FACTOR FOXL2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

CHROMOSOME 10; DORMANCY; FERTILIZATION; GRANULOSA CELL; HUMAN; MAMMAL; NONHUMAN; OOCYTE; OOCYTE DEVELOPMENT; OVARY; OVARY DISEASE; OVARY FOLLICLE; PRIMARY OVARIAN DEFECT; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SPERMATOGENESIS;

AGING; ANIMALS; FEMALE; HUMANS; MICE; MICE, TRANSGENIC; MODELS, ANIMAL; OVARIAN FOLLICLE; OVUM;

EID: 68549117062     PISSN: 0163769X     EISSN: None     Source Type: Journal    
DOI: 10.1210/er.2008-0048     Document Type: Review

References (264)

1. McGeeEA, Hsueh AJ 2000 Initial and cyclic recruitment of ovarian follicles. Endocr Rev 21:200-214
2. Vanderhyden B 2002 Molecular basis of ovarian development and function. Front Biosci 7:d2006-d2022
3. Richards JS, Russell DL, Ochsner S, Hsieh M, Doyle KH, Falender AE, Lo YK, Sharma SC 2002 Novel signaling pathways that control ovarian follicular development, ovulation, and luteinization. Recent Prog Horm Res 57:195-220
4. Gougeon A 2004 Dynamics for human follicular growth: morphologic, dynamic, and functional aspects. In: Leung PCK, Adashi EY, eds. The ovary. 2nd ed. San Diego: Elsevier Academic Press; 25-43
5. Elvin JA, Matzuk MM 1998 Mouse models of ovarian failure. Rev Reprod 3:183-195
6. Matzuk MM, Burns KH, Viveiros MM, Eppig JJ 2002 Intercellular communication in the mammalian ovary: oocytes carry the conversation. Science 296:2178-2180
7. Peters H, Byskov AG, Himelstein-Braw R, Faber M 1975 Follicular growth: the basic event in the mouse and human ovary. J Reprod Fertil 45:559-566
8. Wassarman PM, Albertini DF 1994 The mammalian ovum. In: Knobil E, Neill JD, eds. The physiology of reproduction. Vol. 1. New York: Raven Press; 79-122
9. Eppig JJ 2001 Oocyte control of ovarian follicular development and function in mammals. Reproduction 122: 829-838
10. Eppig JJ, Wigglesworth K, Pendola FL 2002 The mammalian oocyte orchestrates the rate of ovarian follicular development. Proc Natl Acad Sci USA 99:2890-2894
11. Albertini DF, Barrett SL 2003 Oocyte-somatic cell communication. Reprod Suppl 61:49-54
12. Borum K 1961 Oogenesis in the mouse. A study of the meiotic prophase. Exp Cell Res 24:495-507
13. Peters H 1969 The development of the mouse ovary from birth to maturity. Acta Endocrinol (Copenh) 62:98-116
14. Maheshwari A, Fowler PA 2008 Primordial follicular assembly in humans-revisited. Zygote 16:285-296
15. Baker TG 1963 A quantitative and cytological study of germ cells in human ovaries. Proc R Soc Lond B Biol Sci 158:417-433
16. Hansen KR, Knowlton NS, Thyer AC, Charleston JS, Soules MR, Klein NA 2008 A new model of reproductive aging: the decline in ovarian non-growing follicle number from birth to menopause. Hum Reprod 23:699-708
17. Block E 1953 A quantitative morphological investigation of the follicular system in newborn female infants. Acta Anat (Basel) 17:201-206
18. Forabosco A, Sforza C, De Pol A, Vizzotto L, Marzona L, Ferrario VF 1991 Morphometric study of the human neonatal ovary. Anat Rec 231:201-208
19. De Pol A, Vaccina F, Forabosco A, Cavazzuti E, Marzona L 1997 Apoptosis of germ cells during human prenatal oogenesis. Hum Reprod 12:2235-2241
20. Pesce M, De FeliciM1994 Apoptosis in mouse primordial germ cells: a study by transmission and scanning electron microscope. Anat Embryol (Berl) 189:435-440
21. Coucouvanis EC, Sherwood SW, Carswell-Crumpton C, Spack EG, Jones PP 1993 Evidence that the mechanism of prenatal germ cell death in the mouse is apoptosis. Exp Cell Res 209:238-247
22. Pepling ME, Spradling AC 2001 Mouse ovarian germ cell cysts undergo programmed breakdown to form primordial follicles. Dev Biol 234:339-351
23. Fortune JE, Cushman RA, Wahl CM, Kito S 2000 The primordial to primary follicle transition. Mol Cell Endocrinol 163:53-60
24. Hirshfield AN 1991 Development of follicles in the mammalian ovary. Int Rev Cytol 124:43-101
25. Broekmans FJ, Knauff EA, te Velde ER, Macklon NS, Fauser BC 2007 Female reproductive ageing: current knowledge and future trends. Trends Endocrinol Metab 18:58-65
26. Johnson J, Canning J, Kaneko T, Pru JK, Tilly JL 2004 Germline stem cells and follicular renewal in the postnatal mammalian ovary. Nature 428:145-150
27. Johnson J, Bagley J, Skaznik-WikielM,Lee HJ,AdamsGB, Niikura Y, Tschudy KS, Tilly JC, Cortes ML, Forkert R, Spitzer T, Iacomini J, Scadden DT, Tilly JL 2005 Oocyte generation in adult mammalian ovaries by putative germ cells in bone marrow and peripheral blood. Cell 122:303-315
28. Zou K, Yuan Z, Yang Z, Luo H, Sun K, Zhou L, Xiang J, Shi L, Yu Q, Zhang Y, Hou R, Wu J 2009 Production of offspring from a germline stem cell line derived from neonatal ovaries. Nat Cell Biol 11:631-636
29. Greenwald GS 1972 Of eggs and follicles. Am J Anat 135: 1-3
30. TingenCM,Bristol-Gould SK, Kiesewetter SE, Wellington JT, Shea L, Woodruff TK 2009 Prepubertal primordial follicle loss in mice is not due to classical apoptotic pathways. Biol Reprod 81:16-25
31. Faddy MJ, Gosden RG 1996 A model conforming the decline in follicle numbers to the age of menopause in women. Hum Reprod 11:1484-1486
32. Makinoda S, Uno Y, Kikuchi T, Tanaka T, Ichinoe K, Fujimoto S, Aging of human granulosa cells. Program of the Satellite Symposium of the 8th International Congress of Endocrinology, Sapporo, Japan, 1998, pp 201-213
33. Hirshfield AN 1989 Granulosa cell proliferation in very small follicles of cycling rats studied by long-term continuous tritiated-thymidine infusion. Biol Reprod 41:309-316
34. Lintern-Moore S, Moore GP 1979 The initiation of follicle and oocyte growth in the mouse ovary. Biol Reprod 20: 773-778
35. Gougeon A, Chainy GB 1987 Morphometric studies of small follicles in ovaries of women at different ages. J Reprod Fertil 81:433-442
36. Cahill LP, Mauléon P 1981 A study of the population of primordial and small follicles in the sheep. J Reprod Fertil 61:201-206
37. Sternlicht AL, Schultz RM 1981 Biochemical studies of mammalian oogenesis: kinetics of accumulation of total and poly(A)-containing RNA during growth of the mouse oocyte. J Exp Zool 215:191-200
38. Schultz RM, Letourneau GE, Wassarman PM 1979 Program of early development in the mammal: changes in the patterns and absolute rates of tubulin and total protein synthesis during oocyte growth in the mouse. Dev Biol 73: 120-133
39. Fair T, Hulshof SC, Hyttel P, Greve T, Boland M 1997 Nucleus ultrastructure and transcriptional activity of bovine oocytes in preantral and early antral follicles. Mol Reprod Dev 46:208-215
40. Reddy P, Liu L, Adhikari D, Jagarlamudi K, Rajareddy S, Shen Y, Du C, Tang W, Hämäläinen T, Peng SL, Lan ZJ, Cooney AJ, Huhtaniemi I, Liu K 2008 Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool. Science 319:611-613
41. Henderson SA, EdwardsRG1968 Chiasma frequency and maternal age in mammals. Nature 218:22-28
42. Hage AJ, Groen-Klevant AC, Welschen R 1978 Follicle growth in the immature rat ovary. Acta Endocrinol (Copenh) 88:375-382
43. Hirshfield AN 1994 Relationship between the supply of primordial follicles and the onset of follicular growth in rats. Biol Reprod 50:421-428
44. Eppig JJ, O'Brien MJ 1996 Development in vitro of mouse oocytes from primordial follicles. Biol Reprod 54:197-207
45. O'Brien MJ, Pendola JK, Eppig JJ 2003 A revised protocol for in vitro development of mouse oocytes from primordial follicles dramatically improves their developmental competence. Biol Reprod 68:1682-1686
46. Wandji SA, Srsen V, Voss AK, Eppig JJ, Fortune JE 1996 Initiation in vitro of growth of bovine primordial follicles. Biol Reprod 55:942-948
47. Wandji SA, Srsen V, Nathanielsz PW, Eppig JJ, Fortune JE 1997 Initiation of growth of baboon primordial follicles in vitro. Hum Reprod 12:1993-2001
48. Fortune JE, Kito S, Wandji SA, Srsen V 1998 Activation of bovine and baboon primordial follicles in vitro. Theriogenology 49:441-449
49. Silva JR, van den Hurk R, Costa SH, Andrade ER, Nunes AP, Ferreira FV, Lôbo RN, Figueiredo JR 2004 Survival and growth of goat primordial follicles after in vitro culture of ovarian cortical slices in media containing coconut water. Anim Reprod Sci 81:273-286
50. Hovatta O, Silye R, Abir R, Krausz T, Winston RM 1997 Extracellular matrix improves survival of both stored and fresh human primordial and primary ovarian follicles in long-term culture. Hum Reprod 12:1032-1036
51. Hovatta O, Wright C, Krausz T, Hardy K, Winston RM 1999 Human primordial, primary and secondary ovarian follicles in long-term culture: effect of partial isolation. Hum Reprod 14:2519-2524
52. Telfer EE, McLaughlin M, Ding C, Thong KJ 2008 A twostep serum-free culture system supports development of human oocytes from primordial follicles in the presence of activin. Hum Reprod 23:1151-1158
53. Yang MY, Fortune JE 2008 The capacity of primordial follicles in fetal bovine ovaries to initiate growth in vitro develops during mid-gestation and is associated with meiotic arrest of oocytes. Biol Reprod 78:1153-1161
54. Cushman RA, Wahl CM, Fortune JE 2002 Bovine ovarian cortical pieces grafted to chick embryonic membranes: a model for studies on the activation of primordial follicles. Hum Reprod 17:48-54
55. Oktay K, Briggs D, Gosden RG 1997 Ontogeny of folliclestimulating hormone receptor gene expression in isolated human ovarian follicles. J Clin Endocrinol Metab 82: 3748-3751
56. Kumar TR, Wang Y, Lu N, Matzuk MM 1997 Follicle stimulating hormone is required for ovarian follicle maturation but not male fertility. Nat Genet 15:201-204
57. Dierich A, Sairam MR, Monaco L, Fimia GM, Gansmuller A, LeMeur M, Sassone-Corsi P 1998 Impairing folliclestimulating hormone (FSH) signaling in vivo: targeted disruption of the FSH receptor leads to aberrant gametogenesis and hormonal imbalance. Proc Natl Acad Sci USA 95: 13612-13617
58. Abel MH, Wootton AN, Wilkins V, Huhtaniemi I, Knight PG, CharltonHM2000 The effect of a null mutation in the follicle-stimulating hormone receptor gene on mouse reproduction. Endocrinology 141:1795-1803
59. Allan CM, Wang Y, Jimenez M, Marshan B, Spaliviero J, Illingworth P, Handelsman DJ 2006 Follicle-stimulating hormone increases primordial follicle reserve in mature female hypogonadal mice. J Endocrinol 188:549-557
60. Roy SK, Albee L 2000 Requirement for follicle-stimulating hormone action in the formation of primordial follicles during perinatal ovarian development in the hamster. Endocrinology 141:4449-4456
61. Rannikki AS, Zhang FP, Huhtaniemi IT 1995 Ontogeny of follicle-stimulating hormone receptor gene expression in the rat testis and ovary. Mol Cell Endocrinol 107:199-208
62. Tisdall DJ, Watanabe K, Hudson NL, Smith P, McNatty KP 1995 FSH receptor gene expression during ovarian follicle development in sheep. J Mol Endocrinol 15:273-281
63. O'Shaughnessy PJ, Marsh P, Dudley K 1994 Follicle-stimulating hormone receptor mRNA in the mouse ovary during post-natal development in the normal mouse and in the adult hypogonadal (hpg) mouse: structure of alternate transcripts. Mol Cell Endocrinol 101:197-201
64. Arraztoa JA, Zhou J, Marcu D, Cheng C, Bonner R, Chen M, Xiang C, Brownstein M, Maisey K, Imarai M, Bondy C 2005 Identification of genes expressed in primate primordial oocytes. Hum Reprod 20:476-483
65. Kezele PR, Ague JM, Nilsson E, Skinner MK 2005 Alterations in the ovarian transcriptome during primordial follicle assembly and development. Biol Reprod 72:241-255
66. Park CE, Cha KY, Kim K, Lee KA 2005 Expression of cell cycle regulatory genes during primordial-primary follicle transition in the mouse ovary. Fertil Steril 83:410-418
67. Serafica MD, Goto T, Trounson AO 2005 Transcripts from a human primordial follicle cDNA library. Hum Reprod 20:2074-2091
68. YoonSJ,KimKH,ChungHM,ChoiDH,LeeWS,ChaKY, Lee KA 2006 Gene expression profiling of early follicular development in primordial, primary, and secondary follicles. Fertil Steril 85:193-203
69. Manova K, Nocka K, Besmer P, Bachvarova RF 1990 Gonadal expression of c-kit encoded at the W locus of the mouse. Development 110:1057-1069
70. Driancourt MA, Reynaud K, Cortvrindt R, Smitz J 2000 Roles of KIT and KIT LIGAND in ovarian function. Rev Reprod 5:143-152
71. Ismail RS, Okawara Y, Fryer JN, Vanderhyden BC 1996 Hormonal regulation of the ligand for c-kit in the rat ovary and its effects on spontaneous oocyte meiotic maturation. Mol Reprod Dev 43:458-469
72. Liu K, Rajareddy S, Liu L, Jagarlamudi K, Boman K, Selstam G, Reddy P 2006 Control of mammalian oocyte growth and early follicular development by the oocyte PI3 kinase pathway: new roles for an old timer. Dev Biol 299: 1-11
73. Horie K, Takakura K, Taii S, Narimoto K, Noda Y, Nishikawa S, Nakayama H, Fujita J, Mori T 1991 The expression of c-kit protein during oogenesis and early embryonic development. Biol Reprod 45:547-552
74. Orr-Urtreger A, Avivi A, Zimmer Y, Givol D, Yarden Y, Lonai P 1990 Developmental expression of c-kit, a protooncogene encoded by theWlocus. Development 109:911-923
75. Laitinen M, Rutanen EM, Ritvos O 1995 Expression of c-kit ligand messenger ribonucleic acids in human ovaries and regulation of their steady state levels by gonadotropins in cultured granulosa-luteal cells. Endocrinology 136: 4407-4414
76. Manova K, Huang EJ, Angeles M, De Leon V, Sanchez S, Pronovost SM, Besmer P, Bachvarova RF 1993 The expression pattern of the c-kit ligand in gonads of mice supports a role for the c-kit receptor in oocyte growth and in proliferation of spermatogonia. Dev Biol 157:85-99
77. Huang EJ, Manova K, Packer AI, Sanchez S, Bachvarova RF, Besmer P 1993 The murine steel panda mutation affects kit ligand expression and growth of early ovarian follicles. Dev Biol 157:100-109
78. Kuroda H, Terada N, Nakayama H, Matsumoto K, KitamuraY1988 Infertility due to growth arrest of ovarian follicles in Sl/Slt mice. Dev Biol 126:71-79
79. Nilsson E, SkinnerMK2001 Cellular interactions that control primordial follicle development and folliculogenesis. J Soc Gynecol Investig 8:S17-S20
80. Packer AI, Hsu YC, Besmer P, Bachvarova RF 1994 The ligand of the c-kit receptor promotes oocyte growth. Dev Biol 161:194-205
81. Parrott JA, Skinner MK 1999 Kit-ligand/stem cell factor induces primordial follicle development and initiates folliculogenesis. Endocrinology 140:4262-4271
82. Yoshida H, Takakura N, Kataoka H, Kunisada T, Okamura H, Nishikawa SI 1997 Stepwise requirement of c-kit tyrosine kinase in mouse ovarian follicle development. Dev Biol 184: 122-137
83. Chabot B, Stephenson DA, Chapman VM, Besmer P, Bernstein A 1988 The proto-oncogene c-kit encoding a transmembrane tyrosine kinase receptor maps to the mouse W locus. Nature 335:88 -89
84. Flanagan JG, Leder P 1990 The kit ligand: a cell surface molecule altered in steel mutant fibroblasts. Cell 63:185-194
85. Kissel H, Timokhina I, Hardy MP, Rothschild G, Tajima Y, Soares V, Angeles M, Whitlow SR, Manova K, Besmer P 2000 Point mutation in kit receptor tyrosine kinase reveals essential roles for kit signaling in spermatogenesis and oogenesis without affecting other kit responses. EMBO J 19:1312-1326
86. Blume-Jensen P, Jiang G, Hyman R, Lee KF, O'Gorman S, Hunter T 2000 Kit/stem cell factor receptor-induced acti-vation of phosphatidylinositol 3'-kinase is essential for male fertility. Nat Genet 24:157-162
87. Galli SJ, Zsebo KM, Geissler EN 1994 The kit ligand, stem cell factor. Adv Immunol 55:1-96
88. Wandzioch E, Edling CE, PalmerRH,Carlsson L, Hallberg B 2004 Activation of the MAP kinase pathway by c-Kit is PI-3 kinase dependent in hematopoietic progenitor/stem cell lines. Blood 104:51-57
89. Reddy P, Shen L, Ren C, Boman K, Lundin E, Ottander U, Lindgren P, Liu YX, Sun QY, LiuK2005 Activation of Akt (PKB) and suppression of FKHRL1 in mouse and rat oocytes by stem cell factor during follicular activation and development. Dev Biol 281:160-170
90. Liu L, Rajareddy S, Reddy P,DuC, Jagarlamudi K, Shen Y, Gunnarsson D, Selstam G, Boman K, LiuK2007 Infertility caused by retardation of follicular development in mice with oocyte-specific expression of Foxo3a. Development 134:199-209
91. Reddy P, Adhikari D, Zheng W, Liang S, Hamalainen T, Tohonen V, Ogawa W, Noda T, Volarevic S, Huhtaniemi I, Liu K 7 May 2009 PDK1 signaling in oocytes controls reproductive aging and lifespan by manipulating the survival of primordial follicles. Hum Mol Genet 18:2813-2824
92. Liu L, Rajareddy S, Reddy P, Jagarlamudi K,DuC, Shen Y, Guo Y, Boman K, Lundin E, Ottander U, Selstam G, Liu K 2007 Phosphorylation and inactivation of glycogen synthase kinase-3 by soluble kit ligand in mouse oocytes during early follicular development. J Mol Endocrinol 38: 137-146
93. Liu K 2006 Stem cell factor (SCF)-kit mediated phosphatidylinositol 3 (PI3) kinase signaling during mammalian oocyte growth and early follicular development. Front Biosci 11:126-135
94. Engelman JA, Luo J, Cantley LC 2006 The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606-619
95. Stokoe D 2005 The phosphoinositide 3-kinase pathway and cancer. Expert Rev Mol Med 7:1-22
96. Cantley LC 2002 The phosphoinositide 3-kinase pathway. Science 296:1655-1657
97. Simpson L, Parsons R 2001 PTEN: life as a tumor suppressor. Exp Cell Res 264:29-41
98. Fruman DA, Meyers RE, Cantley LC 1998 Phosphoinositide kinases. Annu Rev Biochem 67:481-507
99. Cantrell DA 2001 Phosphoinositide 3-kinase signalling pathways. J Cell Sci 114:1439-1445
100. Pawson T, Nash P 2003 Assembly of cell regulatory systems through protein interaction domains. Science 300: 445-452
101. Schlessinger J 2002 Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110: 669-672
102. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ 1993 SH2 domains recognize specific phosphopeptide sequences. Cell 72:767-778
103. Wu H, Yan Y, Backer JM 2007 Regulation of class IA PI3Ks. Biochem Soc Trans 35:242-244
104. Yu J, Zhang Y, McIlroy J, Rordorf-Nikolic T, Orr GA, Backer JM 1998 Regulation of the p85/p110 phosphatidylinositol 3'-kinase: stabilization and inhibition of the p110α catalytic subunit by the p85 regulatory subunit. Mol Cell Biol 18:1379-1387
105. Cully M, You H, Levine AJ, MakTW2006 Beyond PTEN mutations: the PI3K pathway as an integrator of multiple inputs during tumorigenesis. Nat Rev Cancer 6:184-192
106. Pawson T 2004 Specificity in signal transduction: from phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell 116:191-203
107. Wang J, Auger KR, Jarvis L, Shi Y, Roberts TM 1995 Direct association of Grb2 with the p85 subunit of phosphatidylinositol 3-kinase. J Biol Chem 270:12774-12780
108. Vanhaesebroeck B, Alessi DR 2000 The PI3K-PDK1 connection: more than just a road to PKB. Biochem J 346: 561-576
109. Mora A, Komander D, van Aalten DM, Alessi DR 2004 PDK1, the master regulator of AGC kinase signal transduction. Semin Cell Dev Biol 15:161-170
110. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789
111. Hajduch E, Alessi DR, Hemmings BA, Hundal HS 1998 Constitutive activation of protein kinase B αby membrane targeting promotes glucose and systemAamino acid transport, protein synthesis, and inactivation of glycogen synthase kinase 3 in L6 muscle cells. Diabetes 47:1006-1013
112. Diehl JA, Cheng M, Roussel MF, Sherr CJ 1998 Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization. Genes Dev 12:3499-3511
113. Shin I, Rotty J, Wu FY, Arteaga CL 2005 Phosphorylation of p27Kip1 at Thr-157 interferes with its association with importin αduring G1 and prevents nuclear re-entry. J Biol Chem 280:6055-6063
114. Viglietto G, Motti ML, Bruni P, Melillo RM, D'Alessio A, Califano D, Vinci F, Chiappetta G, Tsichlis P, Bellacosa A, Fusco A, SantoroM2002 Cytoplasmic relocalization and inhibition of the cyclin-dependent kinase inhibitor p27(Kip1) by PKB/Akt-mediated phosphorylation in breast cancer. Nat Med 8:1136-1144
115. Blume-Jensen P, Hunter T 2001 Oncogenic kinase signalling. Nature 411:355-365
116. Arden KC, Biggs 3rd WH 2002 Regulation of the FoxO family of transcription factors by phosphatidylinositol-3 kinase-activated signaling. Arch Biochem Biophys 403: 292-298
117. Accili D, Arden KC 2004 FoxOs at the crossroads of cellular metabolism, differentiation, and transformation. Cell 117:421-426
118. Nakae J, Park BC, Accili D 1999 Insulin stimulates phosphorylation of the forkhead transcription factor FKHR on serine 253 through a Wortmannin-sensitive pathway. J Biol Chem 274:15982-15985
119. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J, Greenberg ME 1999 Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868
120. Yang Q, Guan KL 2007 Expanding mTOR signaling. Cell Res 17:666-681
121. Stokoe D 2001 PTEN. Curr Biol 11:R502
122. Li L, Ross AH 2007 Why is PTEN an important tumor suppressor? J Cell Biochem 102:1368-1374
123. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, Bose S, CallKM,Tsou HC, Peacocke M, Eng C, ParsonsR1997 Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 16:64-67
124. Eng C 1998 Genetics of Cowden syndrome: through the looking glass of oncology. Int J Oncol 12:701-710
125. Suzuki A, de la Pompa JL, Stambolic V, Elia AJ, Sasaki T, del Barco Barrantes I, Ho A, Wakeham A, Itie A, Khoo W, Fukumoto M, Mak TW 1998 High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice. Curr Biol 8:1169-1178
126. Kimura T, Suzuki A, Fujita Y, Yomogida K, Lomeli H, Asada N, Ikeuchi M, Nagy A, Mak TW, Nakano T 2003 Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 130:1691-1700
127. Backman SA, Ghazarian D, So K, Sanchez O, Wagner KU, Hennighausen L, Suzuki A, Tsao MS, Chapman WB, Stambolic V,MakTW2004 Early onset of neoplasia in the prostate and skin of mice with tissue-specific deletion of Pten. Proc Natl Acad Sci USA 101:1725-1730
128. Wang S, Gao J, Lei Q, Rozengurt N, Pritchard C, Jiao J, Thomas GV, Li G, Roy-Burman P, Nelson PS, Liu X, Wu H2003 Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer. Cancer Cell 4:209-221
129. Stanger BZ, Stiles B, Lauwers GY, Bardeesy N, Mendoza M, Wang Y, Greenwood A, Cheng KH, McLaughlin M, Brown D, Depinho RA, Wu H, Melton DA, Dor Y 2005 Pten constrains centroacinar cell expansion and malignant transformation in the pancreas. Cancer Cell 8:185-195
130. Li G, Robinson GW, Lesche R, Martinez-Diaz H, Jiang Z, Rozengurt N, Wagner KU, Wu DC, Lane TF, Liu X, Hennighausen L, Wu H 2002 Conditional loss of PTEN leads to precocious development and neoplasia in the mammary gland. Development 129:4159-4170
131. Yeager N, Klein-Szanto A, Kimura S, Di CristofanoA2007 Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Res 67:959-966
132. Xu X, Kobayashi S, Qiao W, Li C, Xiao C, Radaeva S, Stiles B, Wang RH, Ohara N, Yoshino T, LeRoith D, Torbenson MS, Gores GJ, Wu H, Gao B, Deng CX 2006 Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice. J Clin Invest 116:1843-1852
133. Hernando E, Charytonowicz E, Dudas ME, Menendez S, Matushansky I, Mills J, Socci ND, Behrendt N, Ma L, Maki RG, Pandolfi PP, Cordon-Cardo C 2007 The AKTmTOR pathway plays a critical role in the development of leiomyosarcomas. Nat Med 13:748-753
134. Lan ZJ,XuX, Cooney AJ 2004 Differential oocyte-specific expression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre transgenic mice. Biol Reprod 71: 1469-1474
135. John GB, Gallardo TD, Shirley LJ, Castrillon DH 2008 Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth. Dev Biol 321:197-204
136. Epifano O, Liang LF, Familari M, Moos Jr MC, Dean J 1995 Coordinate expression of the three zona pellucida genes during mouse oogenesis. Development 121:1947-1956
137. Lin K, Hsin H, Libina N, KenyonC2001 Regulation of the Caenorhabditis elegans longevity protein DAF-16 by insulin/ IGF-1 and germline signaling. Nat Genet 28:139-145
138. Libina N, Berman JR, Kenyon C 2003 Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell 115:489-502
139. Giannakou ME, Goss M, Jünger MA, Hafen E, Leevers SJ, Partridge L 2004 Long-lived Drosophila with overexpressed dFOXO in adult fat body. Science 305:361
140. Castrillon DH, Miao L, Kollipara R, Horner JW, DePinho RA 2003 Suppression of ovarian follicle activation in mice by the transcription factor Foxo3a. Science 301:215-218
141. GallardoTD,JohnGB,Bradshaw K, Welt C, Reijo-Pera R, Vogt PH, Touraine P, Bione S, Toniolo D, Nelson LM, Zinn AR, Castrillon DH 2008 Sequence variation at the humanFOXO3locus: a study of premature ovarian failure and primary amenorrhea. Hum Reprod 23:216-221
142. Vinci G, Christin-Maitre S, Pasquier M, Bouchard P, Fellous M, Veitia RA 2008 FOXO3a variants in patients with premature ovarian failure. Clin Endocrinol (Oxf) 68:495-497
143. Watkins WJ, Umbers AJ, Woad KJ, Harris SE, Winship IM, Gersak K, Shelling AN 2006 Mutational screening of FOXO3A and FOXO1A in women with premature ovarian failure. Fertil Steril 86:1518-1521
144. John GB, Shidler MJ, Besmer P, Castrillon DH 15 July 2009 Kit signaling via PI3K promotes ovarian follicle maturation but is dispensable for primordial follicle activation. Dev Biol 331:292-299
145. Nagao S, Murao K, Imachi H, Cao WM, Yu X, Li J, Matsumoto K, Nishiuchi T, Ahmed RA, Wong NC, Ueda K, Ishida T 2006 Platelet derived growth factor regulates ABCA1 expression in vascular smooth muscle cells. FEBS Lett 580:4371-4376
146. Taher TE, Derksen PW, de Boer OJ, Spaargaren M, Teeling P, van der Wal AC, Pals ST 2002 Hepatocyte growth factor triggers signaling cascades mediating vascularsmoothmuscle cell migration. Biochem Biophys Res Commun 298:80-86
147. Chang Y, Wang J, Lu X, Thewke DP, Mason RJ 2005KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J Lipid Res 46:2624-2635
148. Bao S, Wang Y, Sweeney P, Chaudhuri A, Doseff AI, Marsh CB, Knoell DL 2005 Keratinocyte growth factor induces Akt kinase activity and inhibits Fas-mediated apoptosis in A549 lung epithelial cells. Am J Physiol Lung Cell Mol Physiol 288:L36-L42
149. Abid MR, Guo S, Minami T, Spokes KC, Ueki K, Skurk C, Walsh K, AirdWC2004 Vascular endothelial growth factor activates PI3K/Akt/forkhead signaling in endothelial cells. Arterioscler Thromb Vasc Biol 24:294-300
150. Rahbek UL, Dissing S, Thomassen C, Hansen AJ, Tritsaris K 2005 Nerve growth factor activates aorta endothelial cells causing PI3K/Akt- and ERK-dependent migration. Pflugers Arch 450:355-361
151. Srinivasan S, Anitha M, Mwangi S, Heuckeroth RO 2005 Enteric neuroblasts require the phosphatidylinositol 3-kinase/ Akt/Forkhead pathway for GDNF-stimulated survival. Mol Cell Neurosci 29:107-119
152. Sleer LS, TaylorCC2007 Cell-type localization of plateletderived growth factors and receptors in the postnatal rat ovary and follicle. Biol Reprod 76:379-390
153. Pinkas H, Fisch B, Rozansky G, Felz C, Kessler-Icekson G, Krissi H, Nitke S, Ao A, Abir R 2008 Platelet-derived growth factors (PDGF-A and -B) and their receptors in human fetal and adult ovaries. Mol Hum Reprod 14:199-206
154. Abir R, Fisch B, Zhang XY, Felz C, Kessler-Icekson G, Krissi H, Nitke S, Ao A 2009 Keratinocyte growth factor and its receptor in human ovaries from fetuses, girls and women. Mol Hum Reprod 15:69-75
155. Dissen GA, Romero C, Hirshfield AN, Ojeda SR 2001 Nerve growth factor is required for early follicular development in the mammalian ovary. Endocrinology 142: 2078-2086
156. Dissen GA, Hill DF, Costa ME, Ma YJ, Ojeda SR 1991 Nerve growth factor receptors in the peripubertal rat ovary. Mol Endocrinol 5:1642-1650
157. Da Silva-Buttkus P, Marcelli G, Franks S, Stark J, Hardy K 2009 Inferring biological mechanisms from spatial analysis: prediction of a local inhibitor in the ovary. Proc Natl Acad Sci USA 106:456-461
158. Fero ML, Rivkin M, Tasch M, Porter P, Carow CE, Firpo E, Polyak K, Tsai LH, Broudy V, Perlmutter RM, Kaushansky K, Roberts JM 1996 A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell 85:733-744
159. Kaldis P 2007 Another piece of the p27Kip1 puzzle. Cell 128:241-244
160. Sherr CJ, Roberts JM 1999 CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13:1501-1512
161. Kiyokawa H, Kineman RD, Manova-Todorova KO, Soares VC, Hoffman ES, Ono M, Khanam D, Hayday AC, Frohman LA, Koff A 1996 Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell 85:721-732
162. Nakayama K, Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, Horii I, Loh DY, Nakayama K 1996 Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell 85:707-720
163. Aleem E, Kiyokawa H, Kaldis P 2005 Cdc2-cyclin E complexes regulate the G1/S phase transition. Nat Cell Biol 7:831-836
164. Rajareddy S, Reddy P, Du C, Liu L, Jagarlamudi K, Tang W, Shen Y, Berthet C, Peng SL, Kaldis P, Liu K 2007 p27kip1 (cyclin-dependent kinase inhibitor 1B) controls ovarian development by suppressing follicle endowment and activation and promoting follicle atresia in mice. Mol Endocrinol 21:2189-2202
165. Cunningham MA, Zhu Q, Hammond JM 2004 FoxO1a can alter cell cycle progression by regulating the nuclear localization of p27kip in granulosa cells. Mol Endocrinol 18:1756-1767
166. Chandramohan V, Jeay S, Pianetti S, Sonenshein GE 2004 Reciprocal control of Forkhead box O 3a and c-Myc via the phosphatidylinositol 3-kinase pathway coordinately regulates p27Kip1 levels. J Immunol 172:5522-5527
167. Dijkers PF, Medema RH, Pals C, Banerji L, Thomas NS, Lam EW, Burgering BM, Raaijmakers JA, Lammers JW, Koenderman L, Coffer PJ 2000 Forkhead transcription factorFKHR-L1modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol 20:9138-9148
168. Crisponi L, Deiana M, Loi A, Chiappe F, Uda M, Amati P, Bisceglia L, Zelante L, Nagaraja R, Porcu S, Ristaldi MS, Marzella R, Rocchi M, Nicolino M, Lienhardt-Roussie A, Nivelon A, Verloes A, Schlessinger D, Gasparini P, Bonneau D, Cao A, Pilia G 2001 The putative forkhead transcription factorFOXL2is mutated in blepharophimosis/ptosis/epicanthus inversus syndrome. Nat Genet 27:159-166
169. De Baere E, Beysen D, Oley C, Lorenz B, Cocquet J, De Sutter P, Devriendt K, Dixon M, Fellous M, Fryns JP, Garza A, Jonsrud C, Koivisto PA, Krause A, Leroy BP, Meire F, Plomp A, Van Maldergem L, De Paepe A, Veitia R, Messiaen L 2003 FOXL2 and BPES: mutational hotspots, phenotypic variability, and revision of the genotypephenotype correlation. Am J Hum Genet 72:478-487
170. Udar N, Yellore V, Chalukya M, Yelchits S, Silva-Garcia R, Small K 2003 Comparative analysis of the FOXL2 gene and characterization of mutations in BPES patients. Hum Mutat 22:222-228
171. Zlotogora J, Sagi M, Cohen T 1983 The blepharophimosis, ptosis, and epicanthus inversus syndrome: delineation of two types. Am J Hum Genet 35:1020-1027
172. Nallathambi J, Neethirajan G, Usha K, Jitendra J,DeBaere E, Sundaresan P 2007 FOXL2 mutations in Indian families with blepharophimosis-ptosis- epicanthus inversus syndrome. J Genet 86:165-168
173. Cocquet J, Pailhoux E, Jaubert F, Servel N, Xia X, Pannetier M, De Baere E, Messiaen L, Cotinot C, Fellous M, VeitiaRA 2002 Evolution and expression of FOXL2. J Med Genet 39: 916-921
174. Schmidt D, Ovitt CE, Anlag K, Fehsenfeld S, Gredsted L, Treier AC, TreierM2004 The murine winged-helix transcription factor Foxl2 is required for granulosa cell differentiation and ovary maintenance. Development 131:933-942
175. Uda M, Ottolenghi C, Crisponi L, Garcia JE, Deiana M, Kimber W, Forabosco A, Cao A, Schlessinger D, Pilia G 2004 Foxl2 disruption causes mouse ovarian failure by pervasive blockage of follicle development. Hum Mol Genet 13:1171-1181
176. Pisarska MD, Bae J, Klein C, Hsueh AJ 2004 Forkhead l2 is expressed in the ovary and represses the promoter activity of the steroidogenic acute regulatory gene. Endocrinology 145:3424-3433
177. Loffler KA, Zarkower D, Koopman P 2003 Etiology of ovarian failure in blepharophimosis ptosis epicanthus inversus syndrome: FOXL2 is a conserved, early-acting gene in vertebrate ovarian development. Endocrinology 144: 3237-3243
178. Dong J, Albertini DF, Nishimori K, Kumar TR, Lu N, Matzuk MM 1996 Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383: 531-535
179. Elvin JA, Yan C, Wang P, Nishimori K, MatzukMM1999 Molecular characterization of the follicle defects in the growth differentiation factor 9-deficient ovary. Mol Endocrinol 13:1018-1034
180. Uhlenhaut NH, TreierM2006 Foxl2 function in ovarian development. Mol Genet Metab 88:225-234
181. Snider WD 1994 Functions of the neurotrophins during nervous system development: what the knockouts are teaching us. Cell 77:627-638 182. Tessarollo L 1998 Pleiotropic functions of neurotrophins in development. Cytokine Growth Factor Rev 9:125-137
182. Dissen GA, Garcia-Rudaz C, Ojeda SR 2009 Role of neurotrophic factors in early ovarian development. Semin Reprod Med 27:24-31
183. Ojeda SR, Romero C, Tapia V, Dissen GA 2000 Neurotrophic and cell-cell dependent control of early follicular development. Mol Cell Endocrinol 163:67-71
184. Anderson RA, Robinson LL, Brooks J, Spears N 2002 Neurotropins and their receptors are expressed in the human fetal ovary. J Clin Endocrinol Metab 87:890-897
185. Abir R, Fisch B, Jin S, Barnnet M, Ben-Haroush A, Felz C, Kessler-Icekson G, Feldberg D, Nitke S, Ao A 2005 Presence of NGF and its receptors in ovaries from human fetuses and adults. Mol Hum Reprod 11:229-236
186. Paredes A, Romero C, Dissen GA, DeChiara TM, Reichardt L, Cornea A, Ojeda SR, Xu B 2004 TrkB receptors are required for follicular growth and oocyte survival in the mammalian ovary. Dev Biol 267:430-449
187. Conover JC, Erickson JT, Katz DM, Bianchi LM, Poueymirou WT, McClain J, Pan L, Helgren M, Ip NY, Boland P 1995 Neuronal deficits, not involving motor neurons, in mice lackingBDNFand/or NT4. Nature 375:235-238
188. Dole G, Nilsson EE, Skinner MK 2008 Glial-derived neurotrophic factor promotes ovarian primordial follicle development and cell-cell interactions during folliculogenesis. Reproduction 135:671-682
189. Saavedra A, Baltazar G, Duarte EP 2008 Driving GDNF expression: the green and the red traffic lights. Prog Neurobiol 86:186-215
190. Yu N, Roy SK 1999 Development of primordial and prenatal follicles from undifferentiated somatic cells and oocytes in the hamster prenatal ovary in vitro: effect of insulin. Biol Reprod 61:1558-1567
191. Kezele PR, Nilsson EE, Skinner MK 2002 Insulin but not insulin-like growth factor-1 promotes the primordial to primary follicle transition. Mol Cell Endocrinol 192: 37-43
192. Nilsson E, Parrott JA, Skinner MK 2001 Basic fibroblast growth factor induces primordial follicle development and initiates folliculogenesis. Mol Cell Endocrinol 175:123-130
193. Nilsson EE, Skinner MK 2004 Kit ligand and basic fibroblast growth factor interactions in the induction of ovarian primordial to primary follicle transition. Mol Cell Endocrinol 214:19-25
194. Kezele P, Nilsson EE, Skinner MK 2005 Keratinocyte growth factor acts as a mesenchymal factor that promotes ovarian primordial to primary follicle transition. Biol Reprod 73:967-973
195. Nilsson EE, Detzel C, Skinner MK 2006 Platelet-derived growth factor modulates the primordial to primary follicle transition. Reproduction 131:1007-1015
196. Hutt KJ, McLaughlin EA, Holland MK 2006 KIT/KIT ligand in mammalian oogenesis and folliculogenesis: roles in rabbit and murine ovarian follicle activation and oocyte growth. Biol Reprod 75:421-433
197. Massagué J, Chen YG 2000 Controlling TGF-β signaling. Genes Dev 14:627-644
198. Josso N 1973 In vitro synthesis of Mullerian-inhibiting hormone by seminiferous tubules isolated from the calf fetal testis. Endocrinology 93:829-834
199. Donahoe PK, Ito Y,MorikawaY, HendrenWH1977 Mullerian inhibiting substance in human testes after birth. J Pediatr Surg 12:323-330
200. Taguchi O, Cunha GR, Lawrence WD, Robboy SJ 1984 Timing and irreversibility of Mullerian duct inhibition in the embryonic reproductive tract of the human male. Dev Biol 106:394-398
201. Vigier B, Picard JY, Tran D, Legeai L, Josso N 1984 Production of anti-Mullerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 114: 1315-1320
202. Takahashi M, Hayashi M, Manganaro TF, Donahoe PK 1986 The ontogeny of mullerian inhibiting substance in granulosa cells of the bovine ovarian follicle. Biol Reprod 35:447-453
203. Bézard J, Vigier B, Tran D, Mauléon P, Josso N 1987 Immunocytochemical study of anti-Mullerian hormone in sheep ovarian follicles during fetal and post-natal development. J Reprod Fertil 80:509-516
204. Rajpert-De Meyts E, Jørgensen N, Graem N, Müller J, Cate RL, Skakkebaek NE 1999 Expression of anti-Mullerian hormone during normal and pathological gonadal development: association with differentiation of Sertoli and granulosa cells. J Clin Endocrinol Metab 84:3836-3844
205. Lee MM, Donahoe PK, Hasegawa T, Silverman B, Crist GB, Best S, Hasegawa Y, Noto RA, Schoenfeld D, MacLaughlin DT 1996 Mullerian inhibiting substance in humans: normal levels from infancy to adulthood. J Clin Endocrinol Metab 81:571-576
206. de Vet A, Laven JS, de Jong FH, Themmen AP, Fauser BC 2002 Antimullerian hormone serum levels: a putative marker for ovarian aging. Fertil Steril 77:357-362
207. Hirobe S, HeWW,LeeMM,Donahoe PK 1992 Mullerian inhibiting substance messenger ribonucleic acid expression in granulosa and Sertoli cells coincides with their mitotic activity. Endocrinology 131:854-862
208. Baarends WM, Uilenbroek JT, Kramer P, Hoogerbrugge JW, van Leeuwen EC, Themmen AP, Grootegoed JA 1995 Anti-mullerian hormone and anti-mullerian hormone type II receptor messenger ribonucleic acid expression in rat ovaries during postnatal development, the estrous cycle, and gonadotropin-induced follicle growth. Endocrinology 136:4951-4962
209. Durlinger AL, Visser JA, Themmen AP 2002 Regulation of ovarian function: the role of anti-Mullerian hormone. Reproduction 124:601-609
210. Weenen C, Laven JS,VonBergh AR, CranfieldM,Groome NP, Visser JA, Kramer P, Fauser BC, Themmen AP 2004 Anti-Mullerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. Mol Hum Reprod 10:77-83
211. Durlinger AL, Kramer P, Karels B, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP 1999 Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary. Endocrinology 140:5789-5796
212. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Kumar TR, Matzuk MM, Rose UM, de Jong FH, Uilenbroek JT, Grootegoed JA, Themmen AP 2001 Anti-Mullerian hormone attenuates the effects of FSH on follicle development in the mouse ovary. Endocrinology 142:4891-4899
213. Durlinger AL, Gruijters MJ, Kramer P, Karels B, Ingraham HA, Nachtigal MW, Uilenbroek JT, Grootegoed JA, Themmen AP 2002 Anti-Mullerian hormone inhibits initiation of primordial follicle growth in the mouse ovary. Endocrinology 143:1076-1084
214. Carlsson IB, Scott JE, Visser JA, Ritvos O, Themmen AP, Hovatta O 2006 Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro. Hum Reprod 21:2223-2227
215. Nilsson E, Rogers N, Skinner MK 2007 Actions of anti-Mullerian hormone on the ovarian transcriptome to inhibit primordial to primary follicle transition. Reproduction 134:209-221
216. Gigli I, Cushman RA, Wahl CM, Fortune JE 2005 Evidence for a role for anti-Mullerian hormone in the suppression of follicle activation in mouse ovaries and bovine ovarian cortex grafted beneath the chick chorioallantoic membrane. Mol Reprod Dev 71:480-488
217. Schmidt KL, Kryger-Baggesen N, Byskov AG, Andersen CY 2005 Anti-Mullerian hormone initiates growth of human primordial follicles in vitro. Mol Cell Endocrinol 234: 87-93
218. Shimasaki S, Zachow RJ, Li D, Kim H, Iemura S, Ueno N, Sampath K, Chang RJ, Erickson GF 1999 A functional bone morphogenetic protein system in the ovary. Proc Natl Acad Sci USA 96:7282-7287
219. Lee WS, Otsuka F, Moore RK, Shimasaki S 2001 Effect of bone morphogenetic protein-7 on folliculogenesis and ovulation in the rat. Biol Reprod 65:994-999
220. Lee WS, Yoon SJ, Yoon TK, Cha KY, Lee SH, Shimasaki S, Lee S, LeeKA2004 Effects of bone morphogenetic protein-7 (BMP-7) on primordial follicular growth in the mouse ovary. Mol Reprod Dev 69:159-163
221. Nilsson EE, SkinnerMK2003 Bone morphogenetic protein-4 acts as an ovarian follicle survival factor and promotes primordial follicle development. Biol Reprod 69:1265-1272
222. Carabatsos MJ, Elvin J, Matzuk MM, Albertini DF 1998 Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev Biol 204:373-384
223. Erickson GF 2001 Role of growth factors in ovary organogenesis. J Soc Gynecol Investig 8:S13-S16
224. Nilsson EE, SkinnerMK2002 Growth and differentiation factor-9 stimulates progression of early primary but not primordial rat ovarian follicle development. Biol Reprod 67:1018-1024
225. Hreinsson JG, Scott JE, Rasmussen C, Swahn ML, Hsueh AJ, Hovatta O 2002 Growth differentiation factor-9 promotes the growth, development, and survival of human ovarian follicles in organ culture. J Clin Endocrinol Metab 87:316-321
226. Martins FS, Celestino JJ, Saraiva MV, Matos MH, Bruno JB, Rocha-Junior CM, Lima-Verde IB, Lucci CM, Báo SN, Figueiredo JR 2008 Growth and differentiation factor-9 stimulates activation of goat primordial follicles in vitro and their progression to secondary follicles. Reprod Fertil Dev 20:916-924
227. Wang J, Roy SK 2004 Growth differentiation factor-9 and stem cell factor promote primordial follicle formation in the hamster: modulation by follicle-stimulating hormone. Biol Reprod 70:577-585
228. Vitt UA, McGee EA, Hayashi M, Hsueh AJ 2000 In vivo treatment with GDF-9 stimulates primordial and primary follicle progression and theca cell markerCYP17in ovaries of immature rats. Endocrinology 141:3814-3820
229. Xu J, Oakley J, McGee EA 2002 Stage-specific expression of Smad2 and Smad3 during folliculogenesis. Biol Reprod 66:1571-1578
230. Tomic D, Brodie SG, Deng C, Hickey RJ, Babus JK, Malkas LH, Flaws JA 2002 Smad 3 may regulate follicular growth in the mouse ovary. Biol Reprod 66:917-923
231. Tomic D, Miller KP, Kenny HA, Woodruff TK, Hoyer P, Flaws JA 2004 Ovarian follicle development requires Smad3. Mol Endocrinol 18:2224-2240
232. SlotKA,Kastelijn J, Bachelot A, Kelly PA, Binart N, Teerds KJ 2006 Reduced recruitment and survival of primordial and growing follicles in GH receptor-deficient mice. Reproduction 131:525-532
233. Arici A, Oral E, Bahtiyar O, Engin O, Seli E, Jones EE 1997 Leukaemia inhibitory factor expression in human follicular fluid and ovarian cells. Hum Reprod 12:1233-1239
234. Coskun S, Uzumcu M, Jaroudi K, Hollanders JM, Parhar RS, al-Sedairy ST 1998 Presence of leukemia inhibitory factor and interleukin-12 in human follicular fluid during follicular growth. Am J Reprod Immunol 40:13-18
235. Morita Y, Manganaro TF, Tao XJ, Martimbeau S, Donahoe PK, Tilly JL 1999 Requirement for phosphatidylinositol-3'-kinase in cytokine-mediated germ cell survival during fetal oogenesis in the mouse. Endocrinology 140:941-949
236. Nilsson EE, Kezele P, Skinner MK 2002 Leukemia inhibitory factor (LIF) promotes the primordial to primary follicle transition in rat ovaries. Mol Cell Endocrinol 188: 65-73
237. Holt JE, Jackson A, Roman SD, Aitken RJ, Koopman P, McLaughlin EA 2006 CXCR4/SDF1 interaction inhibits the primordial to primary follicle transition in the neonatal mouse ovary. Dev Biol 293:449-460
238. Kezele P, SkinnerMK2003 Regulation of ovarian primordial follicle assembly and development by estrogen and progesterone: endocrine model of follicle assembly. Endocrinology 144:3329-3337
239. Britt KL, Saunders PK, McPherson SJ, Misso ML, Simpson ER, Findlay JK 2004 Estrogen actions on follicle formation and early follicle development. Biol Reprod 71:1712-1723
240. Vendola K, Zhou J, Wang J, Famuyiwa OA, Bievre M, Bondy CA 1999 Androgens promote oocyte insulin-like growth factor I expression and initiation of follicle development in the primate ovary. Biol Reprod 61:353-357
241. Rajkovic A, Pangas SA, Ballow D, Suzumori N, Matzuk MM2004 NOBOX deficiency disrupts early folliculogenesis and oocyte-specific gene expression. Science 305: 1157-1159
242. Choi Y, Rajkovic A 2006 Characterization of NOBOX DNA binding specificity and its regulation of Gdf9 and Pou5f1 promoters. J Biol Chem 281:35747-35756
243. Suzumori N, Yan C, Matzuk MM, Rajkovic A 2002 Nobox is a homeobox-encoding gene preferentially expressed in primordial and growing oocytes.MechDev 111: 137-141
244. Pangas SA,ChoiY, Ballow DJ,ZhaoY, WestphalH,Matzuk MM, Rajkovic A 2006 Oogenesis requires germ cell-specific transcriptional regulators Sohlh1 and Lhx8. Proc Natl Acad Sci USA 103:8090-8095
245. Choi Y, Ballow DJ, Xin Y, Rajkovic A 2008 Lim homeobox gene, lhx8, is essential for mouse oocyte differentiation and survival. Biol Reprod 79:442-449
246. Choi Y, Yuan D, Rajkovic A 2008 Germ cell-specific transcriptional regulator Sohlh2 is essential for early mouse folliculogenesis and oocyte-specific gene expression. Biol Reprod 79:1176-1182
247. Toyoda S, Miyazaki T, Miyazaki S, Yoshimura T, Yamamoto M, Tashiro F, Yamato E, Miyazaki J 2009 Sohlh2 affects differentiation of KIT positive oocytes and spermatogonia. Dev Biol 325:238-248
248. Faddy MJ, Gosden RG, Gougeon A, Richardson SJ, Nelson JF1992Accelerateddisappearanceofovarianfollicles inmidlife: implications for forecasting menopause. Hum Reprod 7:1342-1346
249. Beck-Peccoz P, Persani L 2006 Premature ovarian failure. Orphanet J Rare Dis 1:9
250. Conway GS, Kaltsas G, Patel A, Davies MC, Jacobs HS 1996 Characterization of idiopathic premature ovarian failure. Fertil Steril 65:337-341
251. Goswami D, Conway GS 2005 Premature ovarian failure. Hum Reprod Update 11:391-410
252. Goswami D, Conway GS 2007 Premature ovarian failure. Horm Res 68:196-202
253. Suzumori N, Pangas SA, Rajkovic A 2007 Candidate genes for premature ovarian failure. Curr Med Chem 14:353-357
254. Woad KJ, Watkins WJ, Prendergast D, Shelling AN 2006 The genetic basis of premature ovarian failure. Aust N Z J Obstet Gynaecol 46:242-244
255. Massin N, Czernichow C, Thibaud E, Kuttenn F, Polak M, Touraine P 2006 Idiopathic premature ovarian failure in 63 young women. Horm Res 65:89-95
256. Bath LE, Wallace WH, Critchley HO 2002 Late effects of the treatment of childhood cancer on the female reproductive system and the potential for fertility preservation. BJOG 109:107-114
257. Wallace WH, Shalet SM, Hendry JH, Morris-Jones PH, Gattamaneni HR 1989 Ovarian failure following abdominal irradiation in childhood: the radiosensitivity of the human oocyte. Br J Radiol 62:995-998
258. Gadducci A, Cosio S, Genazzani AR 2007 Ovarian function and childbearing issues in breast cancer survivors. Gynecol Endocrinol 23:625-631
259. Davis VJ 2006 Female gamete preservation. Cancer 107: 1690-1694
260. Byrne J, Fears TR, GailMH,Pee D, Connelly RR, Austin DF, Holmes GF, Holmes FF, Latourette HB, Meigs JW 1992 Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166:788-793
261. Oktay K, Buyuk E, Davis O, Yermakova I, Veeck L, Rosenwaks Z 2003 Fertility preservation in breast cancer patients: IVF and embryo cryopreservation after ovarian stimulation with tamoxifen. Hum Reprod 18:90-95
262. Hreinsson JG, Otala M, Fridström M, Borgström B, Rasmussen C, Lundqvist M, Tuuri T, Simberg N, Mikkola M, Dunkel L, Hovatta O 2002 Follicles are found in the ovaries of adolescent girls with Turner's syndrome. J Clin Endocrinol Metab 87:3618-3623
263. Oktay K, Nugent D, Newton H, Salha O, Chatterjee P, Gosden RG 1997 Isolation and characterization of primordial follicles from fresh and cryopreserved human ovarian tissue. Fertil Steril 67:481-486
264. Hovatta O 2004 Cryopreservation and culture of human ovarian cortical tissue containing early follicles. Eur J Obstet Gynecol Reprod Biol 113(Suppl 1):S50-S54